CIK 0001756262
- Large accelerated filer
TransMedics Group, Inc.
Sign in to watch- Ticker
- TMDX
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- Phone
- +1 978-552-0900
- Business address
- 200 MINUTEMAN ROAD, ANDOVER, MA, 01810
- Open-market buys, last 90 days
- $109,058
- in 1 filing
- Open-market sales, last 90 days
- $385,464
- in 1 filing
Net −$276,406. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 31 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-15 | Gordon Stephen Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −10,000 | 10,000 | ||
| 2021-07-01 | Carey John F VP of Operations | Exercise or conversion | +1,680 | $2.21 | $4K | 1,680 |
| 2021-07-01 | Carey John F VP of Operations | Sale | −1,480 | $33.60 | $50K | 200 |
| 2021-07-01 | Carey John F VP of Operations | Sale | −200 | $34.05 | $7K | 0 |
| 2021-07-01 | Carey John F VP of Operations | Exercise or conversion · Stock Option (Right to Buy) | −1,680 | 18,993 | ||
| 2021-06-25 | Khayal Tamer I Chief Commercial Officer | Exercise or conversion | +3,899 | $0.28 | $1K | 49,975 |
| 2021-06-25 | Khayal Tamer I Chief Commercial Officer | Sale | −3,899 | $35.06 | $137K | 46,076 |
| 2021-06-25 | Khayal Tamer I Chief Commercial Officer | Exercise or conversion · Stock Option (Right to Buy) | −3,899 | 28,278 | ||
| 2021-06-17 | Gordon Stephen Chief Financial Officer | Exercise or conversion | +10,000 | $0.67 | $7K | 10,000 |
| 2021-06-17 | Gordon Stephen Chief Financial Officer | Sale | −10,000 | $30.00 | $300K | 5,714 |
| 2021-06-17 | Gordon Stephen Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −10,000 | 20,000 | ||
| 2021-06-01 | Gordon Stephen Chief Financial Officer | Exercise or conversion | +5,714 | $0.67 | $4K | 5,714 |
| 2021-06-01 | Gordon Stephen Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −5,714 | 29,999 | ||
| 2021-06-01 | Carey John F VP of Operations | Exercise or conversion | +1,680 | $2.21 | $4K | 1,680 |
| 2021-06-01 | Carey John F VP of Operations | Sale | −1,680 | $26.01 | $44K | 0 |
| 2021-06-01 | Carey John F VP of Operations | Exercise or conversion · Stock Option (Right to Buy) | −1,680 | 20,673 | ||
| 2021-05-27 | Gunderson Thomas James Director | Grant or award · Stock Option (Right to Buy) | +13,500 | 13,500 | ||
| 2021-05-27 | KANIA EDWIN M JR Director | Grant or award · Stock Option (Right to Buy) | +13,500 | 13,500 | ||
| 2021-05-27 | Weill David Director | Grant or award · Stock Option (Right to Buy) | +13,500 | 13,500 | ||
| 2021-05-27 | Basile Edward M Director | Grant or award · Stock Option (Right to Buy) | +13,500 | 13,500 |
Page 43 of 49 · 980 trades